VINCENT MED (01612) has announced that the Group expects to record an unaudited comprehensive profit attributable to the Company's owners of not less than HK$100 million for the year ending December 31, 2025. This compares to an audited comprehensive profit attributable to the Company's owners of approximately HK$69.2 million for the year ended December 31, 2024. Based on the information currently available to the Company, the Board believes that the increase is primarily attributable to the strengthened relationship with a major customer in the imaging disposable products division and the expansion of business scale, which has driven a significant rise in the Group's revenue. Furthermore, the Group has achieved better economies of scale by improving capacity utilization and operational efficiency, thereby enhancing the gross profit margin.